(PHEQ) Morgan Stanley Trust - Ratings and Ratios
Equity, Stocks, Hedging, US Large-Caps, Growth
Description: PHEQ Morgan Stanley Trust
The Morgan Stanley ETF Trust (PHEQ) is an actively managed exchange-traded fund that focuses on capital appreciation by investing in a subset of large-cap U.S. equities, specifically constituents of the Solactive GBS U.S. 500 index at the time of purchase. This strategy implies a selective approach to capturing growth opportunities within the large-cap segment, potentially offering a more nuanced exposure compared to broader market indices.
Analyzing the funds characteristics, its categorized under Equity Hedged ETFs, suggesting its investment strategy may incorporate hedging techniques to mitigate potential downsides or capitalize on market inefficiencies. The funds underlying assets are equity securities of large-cap U.S. companies, which typically possess the characteristics of liquidity, stability, and market leadership, potentially offering a balance between growth and risk management.
Examining the technical indicators, the funds price action relative to its moving averages (SMA20: 28.66, SMA50: 28.47, SMA200: 28.84) and the current price (29.78) indicates a bullish short-term trend, as it is trading above its short, medium, and long-term moving averages. The Average True Range (ATR) of 0.42 or 1.42% suggests relatively contained volatility, which could be appealing to investors seeking exposure with managed risk. The 52-week high and low range (30.44 to 26.62) further contextualizes the current price within its recent trading history, showing a recovery or growth from its lows.
From a fundamental perspective, the Assets Under Management (AUM) of $92.93M USD indicate a relatively modest size, which could be a double-edged sword; it might limit the funds ability to diversify extensively but also suggests potential for agility in its investment strategy. The Equity Hedged category implies a strategic approach to risk management, potentially making it an attractive option for investors looking to balance their portfolios against market downturns or volatility.
Forecasting the funds trajectory involves synthesizing technical and fundamental insights. Given its current price above key moving averages and relatively low volatility, the technical outlook is cautiously optimistic. If the AUM continues to grow, it could enhance the funds stability and attract more investors, potentially driving the price upwards. Conversely, failure to attract new capital or significant outflows could pressure the price. Assuming the Solactive GBS U.S. 500 index continues to perform well and the funds hedging strategy effectively manages downside risk, PHEQ could see further capital appreciation. A potential target could be the 52-week high of 30.44, representing a 2.2% increase from the current price, though this would depend on broader market conditions and the funds ability to maintain its strategic edge.
PHEQ ETF Overview
Market Cap in USD | 101m |
Category | Equity Hedged |
TER | 0.29% |
IPO / Inception | 2023-10-16 |
PHEQ ETF Ratings
Growth Rating | 51.2 |
Fundamental | - |
Dividend Rating | 17.0 |
Rel. Strength | -5.66 |
Analysts | - |
Fair Price Momentum | 28.54 USD |
Fair Price DCF | - |
PHEQ Dividends
Dividend Yield 12m | 1.36% |
Yield on Cost 5y | 1.73% |
Annual Growth 5y | -4.21% |
Payout Consistency | 95.7% |
Payout Ratio | % |
PHEQ Growth Ratios
Growth Correlation 3m | 96.9% |
Growth Correlation 12m | 64.6% |
Growth Correlation 5y | 92.7% |
CAGR 5y | 16.02% |
CAGR/Max DD 5y | 1.28 |
Sharpe Ratio 12m | 1.50 |
Alpha | 1.84 |
Beta | 0.541 |
Volatility | 7.06% |
Current Volume | 6.7k |
Average Volume 20d | 6.4k |
Stop Loss | 30.1 (-3.3%) |
As of August 08, 2025, the stock is trading at USD 31.13 with a total of 6,659 shares traded.
Over the past week, the price has changed by +0.13%, over one month by +1.30%, over three months by +8.97% and over the past year by +16.44%.
Partly, yes. Based on ValueRay´s Analyses, Morgan Stanley Trust (NYSE ARCA:PHEQ) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.15 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PHEQ is around 28.54 USD . This means that PHEQ is currently overvalued and has a potential downside of -8.32%.
Morgan Stanley Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, PHEQ Morgan Stanley Trust will be worth about 33.5 in August 2026. The stock is currently trading at 31.13. This means that the stock has a potential upside of +7.65%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 33.5 | 7.6% |
PHEQ Fundamental Data Overview
[93m CCE Cash And Equivalents = unknown
[39m[93m Revenue TTM is 0, using Net Income TTM (False) + Cost of Revenue (False) = 0.0 USD
[39m Revenue TTM = 0.0 USD
EBIT TTM = (False) USD
EBITDA TTM = (False) USD
[93m Debt = unknown
[39m Enterprise Value = 101.2m USD (Market Cap 101.2m + (null Debt) - CCE unknown)
[93m Interest Coverage Ratio = unknown (Ebit TTM (False) / Interest Expense TTM (False))
[39m[93m FCF Yield = N/A (FCF TTM (False) / Enterprise Value 101.2m)
[39m[93m FCF Margin = unknown (Revenue TTM is 0)
[39m[93m Net Margin = unknown
[39m[93m Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM (False)) / Revenue TTM)
[39m[93m Tobins Q-Ratio = unknown (Enterprise Value 101248124.0 / Book Value Of Equity False)
[39m Interest Expense / Debt = 0.0% (Interest Expense (False) / Debt N/A)
[93m Taxrate = 21% (can't be calculated, taking the US default taxrate)
[39m[93m NOPAT = unkown (taxrate: 0.21)
[39m[93m Current Ratio = unknown (Total Current Assets (False) / Total Current Liabilities (False))
[39m[93m Debt / Equity = unknown Debt (N/A)
[39m[93m Debt / EBITDA = unknown (Net Debt N/A / EBITDA (False))
[39m[93m Debt / FCF = N/A (Debt N/A / FCF TTM (False))
[39m[93m Total Stockholder Equity = unknown
[39m RoA = N/A%
[93m RoE = unknown (Net Income TTM (False) / Total Stockholder Equity N/A)
[39m[93m RoCE = unknown (Ebit (False) / Total Stockholder Equity N/A + Long Term Debt N/A)
[39m[93m WACC = unknown (needs Market Cap, Debt N/A, Interest Expense 0.0, Taxrate 0.21, CAPM 14.60)
[39m Discount Rate = 14.60% (= CAPM)
[93m Fair Price DCF = unknown (Cash Flow (False))
[39m
Additional Sources for PHEQ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle